ATM is usually rearranged in T-cell prolymphocytic leukaemia (original) (raw)
- Original Paper
- Published: 18 February 1998
- LJA Coignet1 na1,
- SM Abraham1,
- F Yaqub1,
- L Luo2,
- E Matutes1,
- V Brito-Babapulle1,
- I Vořechovský2,
- MJS Dyer1 &
- …
- D Catovsky1
Oncogene volume 16, pages 789–796 (1998)Cite this article
An Erratum to this article was published on 09 June 1998
Abstract
T-prolymphocytic leukaemia (T-PLL) is a rare, sporadic leukaemia similar to a mature T-cell leukaemia seen in some patients with Ataxia Telangiectasia (A-T), a recessive multisystem disorder caused by mutations of the ATM gene at chromosome 11q23. ATM sequence mutations have been reported in 46% of T-PLL cases, but some cases also have karyotypic abnormalities at 11q, including 11q23. This led us to investigate the structure of the ATM locus in a panel of eight cases, two of which had 11q23 abnormalities. As expected, nucleotide changes were detected in some samples. Two remission samples were wild type. To test for structural lesions, DNA fibres were hybridized with a contig of four labelled cosmids spanning the ATM locus. In all samples there were structural lesions and in four samples both alleles were affected. This provides strong evidence for our suggestion that ATM acts as a tumour suppressor during T-PLL tumorigenesis. Some additional role for ATM during T-PLL tumorigenesis is possible since nucleotide changes were present in addition to structural lesions disrupting both alleles. The mechanism of inactivation appeared to be unusual because multiple structural lesions on one allele were often observed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Author notes
- MAR Yuille and LJA Coignet: These authors contributed equally to this work
Authors and Affiliations
- Academic Department of Haematology and Cytogenetics, Institute of Cancer Research–Royal Marsden Hospital NHS Trust, London, SW3, UK
MAR Yuille, LJA Coignet, SM Abraham, F Yaqub, E Matutes, V Brito-Babapulle, MJS Dyer & D Catovsky - Department of Biosciences at NOVUM, Karolinska Institute, 14157, Huddinge, Sweden
L Luo & I Vořechovský
Authors
- MAR Yuille
You can also search for this author inPubMed Google Scholar - LJA Coignet
You can also search for this author inPubMed Google Scholar - SM Abraham
You can also search for this author inPubMed Google Scholar - F Yaqub
You can also search for this author inPubMed Google Scholar - L Luo
You can also search for this author inPubMed Google Scholar - E Matutes
You can also search for this author inPubMed Google Scholar - V Brito-Babapulle
You can also search for this author inPubMed Google Scholar - I Vořechovský
You can also search for this author inPubMed Google Scholar - MJS Dyer
You can also search for this author inPubMed Google Scholar - D Catovsky
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Yuille, M., Coignet, L., Abraham, S. et al. ATM is usually rearranged in T-cell prolymphocytic leukaemia.Oncogene 16, 789–796 (1998). https://doi.org/10.1038/sj.onc.1201603
- Received: 23 July 1997
- Revised: 24 September 1997
- Accepted: 24 September 1997
- Published: 18 February 1998
- Issue Date: 12 February 1998
- DOI: https://doi.org/10.1038/sj.onc.1201603